Bukwang's clevudine to grab bigger market share
Clevudine, the first-domestically-made medication for hepatitis B and licensing-in entity, is challenging Zeffix and Hepsera of GSK.
It recei...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
